# An Open Label, Single Treatment, Single Arm, Multiple Dose Phase-2 Study to Evaluate the Pharmacokinetics, Safety, and Clinical Performance of EscharEx (EX-03) in Participants With Venous Leg Ulcers

> **NCT07692178** · PHASE2 · NOT_YET_RECRUITING · sponsor: **MediWound Ltd** · enrollment: 20 (estimated)

## Conditions studied

- Venous Leg Ulcer (VLU)

## Interventions

- **DRUG:** EX-03

## Key facts

- **NCT ID:** NCT07692178
- **Lead sponsor:** MediWound Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2028-08
- **Final completion:** 2028-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07692178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07692178, "An Open Label, Single Treatment, Single Arm, Multiple Dose Phase-2 Study to Evaluate the Pharmacokinetics, Safety, and Clinical Performance of EscharEx (EX-03) in Participants With Venous Leg Ulcers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07692178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*